KYOWA KIRIN CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Phase III Clinical Study of KW-2246
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 43
- Registration Number
- NCT00683995
A Phase 1 Study of ARQ 197 in Patients With Solid Tumors
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT00609921
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00610103
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT00457782
- Locations
- π¬π§
Christie Hospital, Manchester, United Kingdom
π¬π§Nottingham University NHS Trust, Nottingham, United Kingdom
π¬π§St Bartholomew's Hospital, London, United Kingdom
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 363
- Registration Number
- NCT00455507
Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT00440037
- Locations
- π―π΅
Research Site, Tokyo, Japan
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 107
- Registration Number
- NCT00364468
- Locations
- π―π΅
Kyusyu region, Fukuoka, Nagasaki, Japan
π―π΅Tokai region, Aichi, Japan
π―π΅Kanto region, Gunma, Saitama, Tokyo, Kanagawa, Japan
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-08-03
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT00359840
- Locations
- π―π΅
Tokai region, Aichi, Japan
π―π΅Kanto region, Tochigi, Saitama, Tokyo, Kanagawa, Japan
π―π΅Hokuriku region, Niigata, Ishikawa, Japan
Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-07-24
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00355472
Clinical Study of KW-2246 in Patients With Cancer Pain
- First Posted Date
- 2006-07-24
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00355628
- Locations
- π―π΅
Nagoya Medical Center, Nagoya, Japan
Β© Copyright 2024. All Rights Reserved by MedPath